- Periodontal Regeneration Using the Mixture of Human Tooth-ash and Plaster of Paris in Dogs
-
Gu HR, Jang HS, Kim SW, Park JC, Kim BO
- KMID: 2462846
- J Korean Acad Periodontol.
- 2006 Mar;36(1):15-26.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT
-
Gu HR, Shin DY, Choi HS, Moon CH, Park SC, Kang HJ
- KMID: 1787913
- Blood Res.
- 2015 Mar;50(1):51-53.
- doi: 10.5045/br.2015.50.1.51
Hepatitis B virus (HBV) reactivation has previously occurred in hepatitis B surface antigen-negative patients with malignant lymphoma who received rituximab-based combination chemotherapy. However, few reports have described cases of HBV... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioimmunotherapy with 131I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with 90Y-Ibritumomab Tiuxetan
-
Kang GW, Kang HJ, Shin DY, Gu HR, Choi HS, Lim SM
- KMID: 2313169
- Nucl Med Mol Imaging.
- 2013 Dec;47(4):281-284.
We report a case that demonstrates the efficacy of radioimmunotherapy (RIT) with radioiodinated rituximab (131I-rituximab) for relapsed diffuse large B-cell lymphoma (DLBCL). A 79-year-old male patient with DLBCL initially achieved... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
-
Gu HR, Park SC, Choi SJ, Lee JC, Kim YC, Han CJ, Kim J, Yang KY, Kim YJ, Noh GY, No SH, Jeong JH
- KMID: 2155291
- Clin Mol Hepatol.
- 2015 Mar;21(1):49-59.
- doi: 10.3350/cmh.2015.21.1.49
BACKGROUND/AIMS: Silibinin, the main component of silymarin, is used as a hepatoprotectant and exhibits anticancer effects against various cancer cells. This study evaluated the effects of a combination of silibinin... -
- CITED
-
- Close
- SHARE
-
- Close
